-+ 0.00%
-+ 0.00%
-+ 0.00%
Cardiff Oncology Appoints Leila Alland as Interim Chief Medical Officer
Share
Listen to the news
Cardiff Oncology Appoints Leila Alland as Interim Chief Medical Officer
  • Cardiff Oncology appointed Leila Alland interim chief medical officer, replacing Roger Sidhu, who stepped down.
  • Alland previously served as chief medical officer at PMV Pharma, Affimed and Tarveda Therapeutics.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cardiff Oncology Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610271605PRIMZONEFULLFEED9854400) on October 27, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending